OSAIC HOLDINGS, INC. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 15 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$0112
+3.7%
0.00%
Q4 2021$01080.0%0.00%
Q3 2021$0108
-17.6%
0.00%
Q2 2021$0131
+322.6%
0.00%
Q1 2021$0310.0%0.00%
Q4 2020$031
-3.1%
0.00%
Q3 2020$0320.0%0.00%
Q2 2020$0
-100.0%
32
-95.9%
0.00%
Q1 2020$1,0007860.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q3 2020
NameSharesValueWeighting ↓
IMS Capital Management 20,146$7,0000.00%
VANGUARD GROUP INC 292,603$101,0000.00%
UBS Group AG 25,171$9,0000.00%
IFP Advisors, Inc 1$1,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 112$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 212$00.00%
NORTHERN TRUST CORP 70,536$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders